Arkolith/Insider Trading/BNTX/Form 4

Hanekamp Annemarie

Chief Commercial OfficerBioNTech SE (BNTX) · full profile →Form 4 · filed May 13, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 12, 2026Grant(A)13K—$013K
May 12, 2026Grant(A)10K—$010K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002118987-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML